Ventana's companion Dx to lung cancer drug wins Chinese approval

09/12/2013 | GenomeWeb Daily News (free registration)

Ventana Medical Systems received approval in China for its Ventana ALK Rabbit Monoclonal Primary Antibody test, which is used to pinpoint patients with nonsmall cell lung cancer who are positive for the anaplastic lymphoma kinase fusion gene. The assay has been approved for use as a companion diagnostic test to Pfizer's lung cancer drug Xalkori.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN